LIFECORE BIOMEDICAL, INC. \DE\ — Form 10-Q
Filed August 5, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Paul Josephs (CEO) and Ryan D. Lake (CFO) signed standard Sarbanes-Oxley certifications on August 5, 2026 for the Q2 2026 10-Q filing (period ended June 30, 2026). Both officers certified that the report contains no untrue material statements, that financial statements fairly present the company's condition and results, and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, significant deficiencies, or fraud involving management were disclosed.
Why this rating
Routine SOX certifications; no facts disclosed beyond standard compliance language. No substance about business operations, finances, or material changes.
See more from August 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.